About Alexandra Cantley
Alexandra Cantley is a director at Cirrus Therapeutics.
Form D filings also name Alexandra Cantley as a director at Auron Therapeutics, Crossbow Therapeutics and EpiBiologics.
Alexandra Cantley first appears on SEC filings in 2022.
Experience
This experience comes from Alexandra Cantley's profile and from SEC filings. For roles taken from filings, the years are when the filings name Alexandra Cantley in the role, so the role may have started earlier or lasted longer.
AE
Amplifire eLearning Current
Board Member
2026 – Present
Auron Therapeutics, Inc. Current
Director
2022 – Present · Wellesley, MA
Develops potential treatments for people with cancer and inflammatory diseases.
TR
TRexBio Current
Board Member
2022 – Present
PP
Polaris Partners Current
Partner
2019 – Present
CT
Capstan Therapeutics
Board Observer
2022 – 2025
IT
Inzen Therapeutics
Scientist
2017 – 2019
VP
Vertex Pharmaceuticals
Vertex Fellow
2016 – 2017
HU
Harvard University
Graduate Student
2011 – 2016
CU
Columbia University
Research technician
2009 – 2011
Key Colleagues at Startups
The people Alexandra Cantley works with at each company, as listed on that company's latest Form D.
Auron Therapeutics, Inc. · Form D, Aug 13, 2026
Briggs Morrison
Director
Pini Orbach
Director
Serge Messerlian
Board Director
Victoria Richon
Director
Anna French
Director
KY
Katharine Yen
Founder & CEO, director
Crossbow Therapeutics, Inc. · Form D, Sep 30, 2025
AN
Alexander Nolte
Executive officer
DW
Dmitri Wiederschain
Executive officer
SA
Sakae Asanuma
Director
CB
Charles Baum
Director
Briggs Morrison
Chief Executive Officer and director
IM
Irena Melnikova
Director
AL
Alon Lazarus
Director
TF
Todd Foley
Director
Cirrus Therapeutics, Inc. · Form D, Aug 19, 2025
EpiBiologics, Inc. · Form D/A, Apr 25, 2024
JC
Jason Coloma
Director
AK
Ann Lee-Karlon
CEO and director
SB
Samuel Bjork
Director
MM
Mitchell Mutz
Executive officer and director
SM
Seiji Miyahara
Director
JW
James Wells
Director